Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

A 20-Year Evaluation of LOINC in the United States' Largest Integrated Health System.

Bhargava A, Kim T, Quine DB, Hauser RG.

Arch Pathol Lab Med. 2019 Aug 30. doi: 10.5858/arpa.2019-0055-OA. [Epub ahead of print]

PMID:
31469586
2.

TRIX with treats: the considerable safety benefits of a transfusion medicine registry.

Hauser RG, Hendrickson JE, Tormey CA.

Transfusion. 2019 Aug;59(8):2489-2492. doi: 10.1111/trf.15449. No abstract available.

PMID:
31374148
3.

Incidence of Clostridioides difficile infections among young and middle-aged adults: Veterans Health Administration.

Russo EM, Kuntz J, Yu H, Smith J, Hauser RG, Halchenko Y, Young-Xu Y.

Infect Control Hosp Epidemiol. 2019 Sep;40(9):997-1005. doi: 10.1017/ice.2019.160. Epub 2019 Jul 19.

PMID:
31322101
4.

Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus: The Veteran Birth Cohort.

Njei B, Esserman D, Krishnan S, Ohl M, Tate JP, Hauser RG, Taddei T, Lim J, Justice AC.

Med Care. 2019 Apr;57(4):279-285. doi: 10.1097/MLR.0000000000001071.

PMID:
30807449
5.

Internal insulation breaches in an implantable cardioverter-defibrillator lead with redundant conductors.

Hauser RG, Sengupta J, Schloss EJ, Stanberry LI, Wananu MK, Abdelhadi R.

Heart Rhythm. 2019 Aug;16(8):1215-1222. doi: 10.1016/j.hrthm.2019.02.019. Epub 2019 Feb 14.

6.

Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Karafin MS, Tan S, Tormey CA, Spencer BR, Hauser RG, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Gottschall JL, Hendrickson JE.

Transfusion. 2019 Jan;59(1):217-225. doi: 10.1111/trf.15004. Epub 2018 Nov 14.

PMID:
30427537
7.

Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.

Karafin MS, Westlake M, Hauser RG, Tormey CA, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Hendrickson JE; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Br J Haematol. 2018 Jun;181(5):672-681. doi: 10.1111/bjh.15182. Epub 2018 Apr 19.

8.

Demographic and epidemiologic characterization of transfusion recipients from four US regions: evidence from the REDS-III recipient database.

Karafin MS, Bruhn R, Westlake M, Sullivan MT, Bialkowski W, Edgren G, Roubinian NH, Hauser RG, Kor DJ, Fleischmann D, Gottschall JL, Murphy EL, Triulzi DJ; National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Transfusion. 2017 Dec;57(12):2903-2913. doi: 10.1111/trf.14370. Epub 2017 Oct 24.

9.

Reply to Galen, "Screening Cerebrospinal Fluid Prior to Herpes Simplex Virus PCR Testing Might Miss Cases of Herpes Simplex Encephalitis".

Hauser RG, Campbell SM, Brandt CA, Wang S.

J Clin Microbiol. 2017 Oct;55(10):3144-3145. doi: 10.1128/JCM.01144-17. No abstract available.

10.

Unit conversions between LOINC codes.

Hauser RG, Quine DB, Ryder A, Campbell S.

J Am Med Inform Assoc. 2018 Feb 1;25(2):192-196. doi: 10.1093/jamia/ocx056.

11.

LabRS: A Rosetta stone for retrospective standardization of clinical laboratory test results.

Hauser RG, Quine DB, Ryder A.

J Am Med Inform Assoc. 2018 Feb 1;25(2):121-126. doi: 10.1093/jamia/ocx046.

12.

Criteria to Screen Molecular Tests for the Diagnosis of Herpes Simplex Virus in the Central Nervous System have no Propensity to Harm.

Hauser RG, Brandt CA, Martinello RA.

J Pathol Inform. 2017 Feb 28;8:4. doi: 10.4103/2153-3539.201113. eCollection 2017.

13.

Cost-Effectiveness Study of Criteria for Screening Cerebrospinal Fluid To Determine the Need for Herpes Simplex Virus PCR Testing.

Hauser RG, Campbell SM, Brandt CA, Wang S.

J Clin Microbiol. 2017 May;55(5):1566-1575. doi: 10.1128/JCM.00119-17. Epub 2017 Mar 15.

14.

Eligibility and utilization of implantable cardioverter-defibrillators in a regional STEMI system.

Johnson BK, Garberich RF, Henry TD, Katsiyiannis WT, Sengupta J, Kalra A, Hauser RG, Lardy ME, Newell MC.

Heart Rhythm. 2016 Feb;13(2):538-46. doi: 10.1016/j.hrthm.2015.10.019. Epub 2015 Oct 13.

PMID:
26576706
15.

Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.

Providência R, Kramer DB, Pimenta D, Babu GG, Hatfield LA, Ioannou A, Novak J, Hauser RG, Lambiase PD.

J Am Heart Assoc. 2015 Oct 30;4(11). pii: e002418. doi: 10.1161/JAHA.115.002418. Review.

16.

Underutilization of Implantable Cardioverter-Defibrillators in Older Patients.

Hauser RG.

JAMA. 2015 Jun 23-30;313(24):2429-30. doi: 10.1001/jama.2015.6408. No abstract available.

PMID:
26103025
17.

Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance.

Kramer DB, Hatfield LA, McGriff D, Ellis CR, Gura MT, Samuel M, Retel LK, Hauser RG.

J Am Heart Assoc. 2015 May 29;4(6):e001672. doi: 10.1161/JAHA.114.001672.

18.

A bayesian approach to laboratory utilization management.

Hauser RG, Jackson BR, Shirts BH.

J Pathol Inform. 2015 Feb 24;6:10. doi: 10.4103/2153-3539.151921. eCollection 2015.

19.

Clinical laboratory analytics: Challenges and promise for an emerging discipline.

Shirts BH, Jackson BR, Baird GS, Baron JM, Clements B, Grisson R, Hauser RG, Taylor JR, Terrazas E, Brimhall B.

J Pathol Inform. 2015 Feb 24;6:9. doi: 10.4103/2153-3539.151919. eCollection 2015.

20.

Do we now know what inappropriate laboratory utilization is? An expanded systematic review of laboratory clinical audits.

Hauser RG, Shirts BH.

Am J Clin Pathol. 2014 Jun;141(6):774-83. doi: 10.1309/AJCPX1HIEM4KLGNU. Review.

PMID:
24838320
21.

Peripheral artery disease is an independent predictor of mortality after implantable cardioverter-defibrillator implantation in patients with severe left ventricular dysfunction.

Skeik N, McGriff DM, Katsiyiannis WT, Sullivan TM, Mugglin AS, Retel LM, Hauser RG.

Angiology. 2014 Jul;65(6):507-11. doi: 10.1177/0003319713499607. Epub 2013 Aug 21.

PMID:
23966571
22.

Early fatigue fractures in the IS-1 connector leg of a small-diameter ICD lead: value of returned product analysis for improving device safety.

Hauser RG, Kallinen Retel LM.

Heart Rhythm. 2013 Oct;10(10):1462-8. doi: 10.1016/j.hrthm.2013.07.001. Epub 2013 Jul 16.

PMID:
23871705
23.

Comparison of functional recovery following percutaneous coronary intervention for ST elevation myocardial infarction in three age groups (<70, 70 to 79, and ≥80 years).

Christiansen EC, Wickstrom KK, Henry TD, Garberich RF, Rutten-Ramos SC, Larson DM, Grey EZ, Thiessen NL, Hauser RG, Newell MC.

Am J Cardiol. 2013 Aug 1;112(3):330-5. doi: 10.1016/j.amjcard.2013.03.031. Epub 2013 Apr 30.

PMID:
23642505
24.

Please leave the reliable ICD leads alone.

Hauser RG.

Heart Rhythm. 2013 Apr;10(4):562-3. doi: 10.1016/j.hrthm.2012.12.024. Epub 2012 Dec 27. No abstract available.

PMID:
23274369
25.

Independent multicenter study of Riata and Riata ST implantable cardioverter-defibrillator leads.

Abdelhadi RH, Saba SF, Ellis CR, Mason PK, Kramer DB, Friedman PA, Gura MT, DiMarco JP, Mugglin AS, Reynolds MR, Bazaz RR, Retel LK, Hayes DL, Hauser RG.

Heart Rhythm. 2013 Mar;10(3):361-5. doi: 10.1016/j.hrthm.2012.10.045. Epub 2012 Nov 2.

PMID:
23128017
26.

The subcutaneous implantable cardioverter-defibrillator: should patients want one?

Hauser RG.

J Am Coll Cardiol. 2013 Jan 8;61(1):20-2. doi: 10.1016/j.jacc.2012.07.069. Epub 2012 Nov 1.

27.

Failure of a novel silicone-polyurethane copolymer (Optim™) to prevent implantable cardioverter-defibrillator lead insulation abrasions.

Hauser RG, Abdelhadi RH, McGriff DM, Kallinen Retel L.

Europace. 2013 Feb;15(2):278-83. doi: 10.1093/europace/eus245. Epub 2012 Aug 21.

28.

Lessons from ICD lead recalls: what have we learned?

Hauser RG.

Pacing Clin Electrophysiol. 2012 Jun;35(6):650-1. doi: 10.1111/j.1540-8159.2012.03366.x. Epub 2012 Mar 27. No abstract available.

PMID:
22671710
29.

Riata externalized conductors: cosmetic defect or manifestation of a more serious design flaw?

Hauser RG.

Heart Rhythm. 2012 Aug;9(8):1225-6. doi: 10.1016/j.hrthm.2012.04.010. Epub 2012 Apr 10. No abstract available.

PMID:
22498051
30.

Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads.

Hauser RG, Abdelhadi R, McGriff D, Retel LK.

Heart Rhythm. 2012 Aug;9(8):1227-35. doi: 10.1016/j.hrthm.2012.03.048. Epub 2012 Mar 23.

PMID:
22449741
31.

Early detection of an underperforming implantable cardiovascular device using an automated safety surveillance tool.

Hauser RG, Mugglin AS, Friedman PA, Kramer DB, Kallinen L, McGriff D, Hayes DL.

Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):189-96. doi: 10.1161/CIRCOUTCOMES.111.962621. Epub 2012 Mar 6.

PMID:
22396584
32.

Here we go again--another failure of postmarketing device surveillance.

Hauser RG.

N Engl J Med. 2012 Mar 8;366(10):873-5. doi: 10.1056/NEJMp1114695. Epub 2012 Feb 14. No abstract available.

PMID:
22332951
33.

Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect.

Hauser RG, McGriff D, Retel LK.

Heart Rhythm. 2012 May;9(5):742-9. doi: 10.1016/j.hrthm.2011.12.019. Epub 2011 Dec 28. Erratum in: Heart Rhythm. 2013 Jan;10(1):148.

PMID:
22209723
34.

Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators.

Kramer DB, Friedman PA, Kallinen LM, Morrison TB, Crusan DJ, Hodge DO, Reynolds MR, Hauser RG.

Heart Rhythm. 2012 Jan;9(1):42-6. doi: 10.1016/j.hrthm.2011.08.031. Epub 2011 Sep 3.

PMID:
21893137
35.

Impact of implanted recalled sprint Fidelis lead on patient mortality.

Morrison TB, Friedman PA, Kallinen LM, Hodge DO, Crusan D, Kumar K, Hayes DL, Rea RF, Hauser RG.

J Am Coll Cardiol. 2011 Jul 12;58(3):278-83. doi: 10.1016/j.jacc.2011.03.027.

36.

Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management.

Hauser RG, Maisel WH, Friedman PA, Kallinen LM, Mugglin AS, Kumar K, Hodge DO, Morrison TB, Hayes DL.

Circulation. 2011 Feb 1;123(4):358-63. doi: 10.1161/CIRCULATIONAHA.110.975219. Epub 2011 Jan 17.

PMID:
21242478
37.

Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures.

Kallinen LM, Hauser RG, Tang C, Melby DP, Almquist AK, Katsiyiannis WT, Gornick CC.

Heart Rhythm. 2010 Aug;7(8):1048-55. doi: 10.1016/j.hrthm.2010.05.015. Epub 2010 May 21.

PMID:
20493965
38.

Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.

Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ.

J Am Coll Cardiol. 2010 Jan 26;55(4):333-41. doi: 10.1016/j.jacc.2009.08.057.

39.

Importance of ICD pulse generator longevity.

Hauser RG.

Heart Rhythm. 2009 Dec;6(12):1744. doi: 10.1016/j.hrthm.2009.10.002. Epub 2009 Oct 12. No abstract available.

PMID:
19959122
40.

Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction.

Hauser RG, Katsiyiannis WT, Gornick CC, Almquist AK, Kallinen LM.

Europace. 2010 Mar;12(3):395-401. doi: 10.1093/europace/eup375. Epub 2009 Nov 27.

41.

Development and Industrialization of the Implantable Cardioverter-Defibrillator: A Personal and Historical Perspective.

Hauser RG.

Card Electrophysiol Clin. 2009 Dec;1(1):117-127. doi: 10.1016/j.ccep.2009.08.010. Epub 2009 Oct 23.

PMID:
28770778
42.

Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).

Maisel WH, Hauser RG, Hammill SC, Hauser RG, Ellenbogen KA, Epstein AE, Hayes DL, Alpert JS, Berger RD, Curtis AB, Dubin AM, Estes NA 3rd, Gura MT, Krahn AD, Lampert R, Lindsay BD, Wilkoff BL; Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines; American College of Cardiology (ACC); American Heart Association (AHA).

Heart Rhythm. 2009 Jun;6(6):869-85. doi: 10.1016/j.hrthm.2009.04.024. No abstract available.

PMID:
19467518
43.

Preemption and malpractice liability.

Hauser RG.

N Engl J Med. 2009 May 21;360(21):2257-8; author reply 2258. doi: 10.1056/NEJMc090478. No abstract available.

PMID:
19458378
44.

Monitoring an imperfect lead.

Hauser RG.

Pacing Clin Electrophysiol. 2009 Apr;32(4):541-2. doi: 10.1111/j.1540-8159.2009.02317.x. No abstract available.

PMID:
19335866
45.

Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.

Hauser RG, Hayes DL.

Heart Rhythm. 2009 May;6(5):605-10. doi: 10.1016/j.hrthm.2009.02.024. Epub 2009 Feb 20.

PMID:
19285920
46.

Learning from our mistakes? Testing new ICD technology.

Hauser RG, Almquist AK.

N Engl J Med. 2008 Dec 11;359(24):2517-9. doi: 10.1056/NEJMp0805359. No abstract available.

PMID:
19073974
47.

A better method for preventing adverse clinical events caused by implantable cardioverter-defibrillator lead fractures?

Hauser RG.

Circulation. 2008 Nov 18;118(21):2117-9. doi: 10.1161/CIRCULATIONAHA.108.819870. No abstract available.

PMID:
19015411
48.

Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients.

Hauser RG, Maron BJ, Marine JE, Lampert R, Kadish AH, Winters SL, Scher DL, Biria M, Kalia A.

Heart Rhythm. 2008 Nov;5(11):1517-22. doi: 10.1016/j.hrthm.2008.08.021. Epub 2008 Aug 28.

PMID:
18984525
49.

Proceedings of the ICD Lead Performance Conference.

Maisel WH, Hauser RG.

Heart Rhythm. 2008 Sep;5(9):1331-8. doi: 10.1016/j.hrthm.2008.05.034. Epub 2008 Jun 4. No abstract available.

PMID:
18774113
50.

Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead.

Kallinen LM, Hauser RG, Lee KW, Almquist AK, Katsiyiannis WT, Tang CY, Melby DP, Gornick CC.

Heart Rhythm. 2008 Jun;5(6):775-9. doi: 10.1016/j.hrthm.2008.02.039. Epub 2008 Mar 4.

PMID:
18534361

Supplemental Content

Loading ...
Support Center